Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will VIR-5818 achieve an ORR of 50%+ in HER2 cancers by end of 2025?  | Binary | 3 | 1 day ago | ||
Will VIR-5500 achieve a PSA50 response rate of 70%+ in mCRPC by mid-2025? | Binary | 2 | 1 day ago | ||
Will Vir begin a Phase 3 trial for VIR-5818 or VIR-5500 by end of 2025? | Binary | 2 | 1 day ago | ||
Vir Biotechnology stock price change by end of Q1 2025? | Categorical | 2 | 1 day ago | ||
Will VIR-5818 or VIR-5500 get FDA Fast Track by end of 2025? | Categorical | 2 | 1 day ago | ||
How does VIR-5818's ORR in HER2 cancers compare to Enhertu by end of 2025? | Categorical | 2 | 1 day ago |